BRC

BRC Free Cash Flow

$192.65MTTM · USD

Period ending:

BRC FY Free Cash FlowUSD
BRC FY Free Cash Flow1989-07-31: $8.40M1990-07-31: $6.30M1991-07-31: $2.20M1992-07-31: -$5.70M1993-07-31: $9.30M1994-07-31: $26.60M1995-07-31: $13.50M1996-07-31: $24.10M1997-07-31: $31.10M1998-07-31: $10.70M1999-07-31: $20.40M2000-07-31: $25.78M2001-07-31: $32.46M2002-07-31: $41.16M2003-07-31: $40.81M2004-07-31: $69.88M2005-07-31: $97.18M2006-07-31: $75.49M2007-07-31: $84.08M2008-07-31: $199.15M2009-07-31: $102.62M2010-07-31: $138.94M2011-07-31: $146.82M2012-07-31: $120.56M2013-07-31: $107.82M2014-07-31: $50.02M2015-07-31: $66.68M2016-07-31: $121.84M2017-07-31: $128.87M2018-07-31: $121.27M2019-07-31: $129.39M2020-07-31: $113.70M2021-07-31: $178.48M2022-07-31: $75.31M2023-07-31: $189.92M2024-07-31: $175.18M2025-07-31: $153.62M2026-07-31: $192.65M$199.15M-$5.70M
1989-07-312026-07-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BRC free cash flow history

Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 38 observations from Jul 31, 1989 to Jul 31, 2026.

Brady Corporation Common Stock Free Cash Flow — Annual fiscal periods (USD)
Period endingFree Cash Flow (USD)
192,654,000
153,619,000
175,182,000
189,923,000
75,311,000
178,476,000
113,700,000
129,386,000
121,265,000
128,865,000
121,836,000
66,675,000
50,022,000
107,816,000
120,558,000
146,818,000
138,942,000
102,618,000
199,147,000
84,078,000
75,486,000
97,183,000
69,879,000
40,811,000
41,156,000
32,458,000
25,784,000
20,400,000
10,700,000
31,100,000
24,100,000
13,500,000
26,600,000
9,300,000
-5,700,000
2,200,000
6,300,000
8,400,000

Compare free cash flow

Other companies in —. Each page shows its own reporting periods and currency.

All BRC financial metrics · BRC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.